Efficacy and safety of uterine tamponade to control bleeding and reduce obstetric hysterectomy. Historic cohort in Nuevo León, México, 2013

Authors

  • Yolanda Reynosa-Oviedo
  • Ernesto Arnoldo López-Vera
  • Juan José Bazaldúa-Cruz
  • Gerardo Jesús Martínez-Salazar

DOI:

https://doi.org/10.18597/rcog.23

Keywords:

Uterine tamponade, Sengstaken-Blakemore balloon, Foley balloon catheter, uterine bleeding, obstetric haemorrhage, obstetric surgical procedures

Abstract

Objective: Examine the efficacy and safety of uterine tamponade for controlling obstetric bleeding and reducing the need for obstetric hysterectomy.


Materials and methods: Historic cohort of adult women diagnosed with obstetric bleeding secondary to uterine atony that did not respond to the initial management, with bleeding of the placental bed secondary to abnormal placentation or to incomplete abortion, subjected to uterine tamponade at the Highly Specialized Gynaecology and Obstetrics Medical Unit No. 23, a Level III
Hospital in the city of Monterrey, state of Nuevo Leon, Mexico, between January and December 2013. Information about social, demographic and baseline clinical characteristics, laboratory values before the obstetric event and after the tamponade procedure, as well as the inflation volume of the balloon, the indication of the procedure, the estimated amount of bleeding during the event
and after placement of the tamponade balloon, control of bleeding, and need for hysterectomy, was derived from the clinical record. Descriptive statistics, scatter measurements, and central trends were used.


Results: Overall, 161 patients between the ages of 16 and 42 years, with a diagnosis of obstetric haemorrhage were included, 147 following delivery or caesarean section, and 14 following miscarriage. A satisfactory result was documented in more than 95 % of cases after delivery or caesarean section, and in more than 93 % post abortion cases. The mean tamponade time for both groups was 20 hours.

Conclusions: This study supports the use of uterine tamponade as an effective and safe therapeutic measure to control bleeding and avoid laparotomy
or hysterectomy, and to reduce morbidity.

Author Biographies

Yolanda Reynosa-Oviedo

Miembro del Equipo de Respuesta Inmediata, Unidad Médica de Alta Especialidad No. 23, Hospital de Ginecología y Obstetricia “Dr. Ignacio Morones Prieto”. Instituto Mexicano del Seguro Social (I.M.S.S.), Monterrey, Nuevo León (México)

Ernesto Arnoldo López-Vera

Coordinador clínico y cirujano responsable del equipo de respuesta inmediata de turno vespertino, Unidad Médica de Alta Especialidad No. 23, Hospital de Ginecología y Obstetricia “Dr. Ignacio Morones Prieto”. Instituto Mexicano del Seguro Social (I.M.S.S.), Monterrey,
Nuevo León (México).

Juan José Bazaldúa-Cruz

Miembro del Equipo de Respuesta Inmediata, Unidad Médica de Alta Especialidad No. 23, Hospital de Ginecología y Obstetricia “Dr. Ignacio Morones Prieto”. Instituto Mexicano del Seguro Social (I.M.S.S.), Monterrey, Nuevo León (México).

Gerardo Jesús Martínez-Salazar

Médico residente de Ginecología y Obstetricia, Unidad Médica de Alta Especialidad No. 23, Hospital de Ginecología y Obstetricia “Dr. Ignacio Morones Prieto”. Instituto Mexicano del Seguro Social (I.M.S.S.), Monterrey, Nuevo León (México).

References

World Health Organization. World health statistics 2013. Washington, DC: WHO; 2013.

World Health Organization, UNICEF, UNFPA, The World Bank. Trends in maternal mortality: 1990 to 2010. Washington, DC: WHO; 2012.

Wise A, Clark V. Challenges of major obstetric haemorrhage. Best Pract Res Clin Obstet Gynaecol. 2010; 24:353-65.

Mousa HA, Blum J, Senoun GA, Shakur H, Alfirevic Z. Treatment for primary postpartum hemorrhage. Cochrane Database of Systematic Reviews 2014. CD003249. DOI: 10.1002/14651858.CD003249.pub3.

Lennox C, Marr L. Scottish confidential audit of severe maternal morbidity: reducing avoidable harm. Healthcare Improvement Scotland. 9th anual report; 2011.

Álvarez-Toste M, Hinojosa-Álvarez MC, Salvador-Álvarez S, López-Barroso R, González-Rodríguez G, Carbonell I, et al. Morbilidad materna extremadamente grave, un problema actual. Rev Cubana Hig Epidemiol. 2011;49:420-33.

Suárez-González JA, Gutiérrez-Machado M, Corrales-Gutiérrez A, Benavidez-Casal ME, Carlos-Tempo D. Algunos factores asociados a la morbilidad obstétrica extremadamente grave. Rev Cubana Obstet Ginecol. 2010;36:4-12.

Ruiz-Rosas RA, Cruz-Cruz PC, Torres-Arreola LP. Hemorragia obstétrica, causa de muerte materna. IMSS, 2011. Rev Med Inst Mex Seguro Soc. 2012;50:659-64.

Countdown 2015 decade report (2000-2010): Taking stock of maternal, newborn and child survival. Washington, DC: Who/UNICEF; 2010.

Karlsson H, Pérez-Sanz C. Hemorragia postparto. An Sist Sanit Navar. 2009;32:S159-67.

Vélez-Álvarez G, Agudelo-Jaramillo B. Guía de manejo de la hemorragia obstétrica “Código rojo”. Medellín, Colombia; 2007.

Lennox C, Marr L. Scottish confidential audit of severe maternal morbidity. Healthcare Improvement Scotland. 7th anual report; 2009.

World Health Organization. WHO recommendations for the prevention and treatment of postpartum hemorrhage. Washington, DC: WHO; 2012.

Royal College of Obstetricians and Gynaecologists. Postpartum hemorrhage, prevention and management. RCOG; 2009.

Malvino E, Eisele G, Martínez S, Lowenstein R. Hemorragias obstétricas exanguinantes. Clin Invest Ginecol Obstet. 2011;36:2-8.

Adell A, Araújo A. Manejo multidisciplinario de la hemorragia obstétrica. Servicio Vasco de Salud, San Sebastián, España; 2011.

Dildy GA. Postpartum hemorrhage: new management options. Clin Obstet Gynecol. 2002;45:330-44.

Doumouchtsis SK, Papageorghiou AT, Arulkumaran S. Systematic review of conservative management of postpartum hemorrhage: what to do when medical treatment fails. Obstet Gynecol Surv. 2007;62:540-7.

Danso D, Reginald PW. Internal uterine tamponade. En: Lynch CB, Keith LG, Lalonde AB, Karoshi M, editors. A Text- book of Postpartum Hemorrhage. Duncow, UK: Sapiens Publishing; 2006. p. 263-7.

Douglass LH. The passing of the pack. Bull Sch Med Univ Md.1955;40:389.

Drucker M, Wallach RC. Uterine packing: a reappraisal. Mt Sinai J Med. 1979;46:191-4.

Goldrath MH. Uterine tamponade for the control of acute uterine bleeding. Am J Obstet Gynecol. 1983; 147:869-72.

De-Loor JA, Van-Dam PA. Foley catheters for uncontrollable obstetric or gynecologic hemorrhage. Obstet Gynecol. 1996;88:737.

Condous GS, Arulkumaran S, Symonds I, Chapman R, Sinha A, Razvi K. The “tamponade test” in the management of massive postpartum hemorrhage. Obstet Gynecol. 2003;101:767-72.

Katesmark M, Brown R, Raju KS. Successful use of a Sengstaken-Blakemore tube to control massive postpartum hemorrhage. Br J Obstet Gynaecol. 1994;101:259-60.

Condie RG, Buxton EJ, Payne ES. Successful use of Sengstaken-Blakemore tube to control massive postpartum hemorrhage. Br J Obstet Gynaecol. 1994;101:1023-4.

Bakri YN. Balloon device for control of obstetrical bleeding. Eur J Obstet Gynecol Reprod Biol. 1999; 86:S84.

Georgiou C. Balloon tamponade in the management of postpartum hemorrhage: a review. BJOG 2009; 116:748-57.

Tindell K, Garfinkel R, Abu-Haydar E, Ahn R, Burke TF, Conn K, et al. Uterine balloon tamponade for the treatment of postpartum hemorrhage in resource-poor settings: a systematic review. BJOG. 2013;120:5-14.

Tirumuru S, Saba S, Morsi H, Muammar B. Intrauterine balloon tamponade in the management of severe postpartum hemorrhage: A case series from a busy UK district general hospital. OJOG. 2013;3:131-6.

Ishii T, Sawada K, Koyama S, Isobe A, Wakabayashi A, Takiuchi T, et al. Balloon tamponade during cesarean section is useful for severe post-partum hemorrhage due to placenta previa. J Obstet Gynaecol Res. 2012; 38:102-7.

Johanson R, Kumar M, Obhari M, Young P. Management of massive postpartum hemorrhage: use of a hydrostatic ballon catheter to avoid laparotomy. BJOG. 2001;108:420-2.

Seror J, Allouche C, Elhaik S. Use of Sengstaken-Blakemore tube in massive postpartum hemorrhage: a series of 17 cases. Acta Obstet Gynecol Scand. 2005; 84:660-4.

Khamaiseh K, Al-Ma’ani W, Tahat Y. Intrauterine ballon tamponade in the management of postpartum hemorrhage: Experience at the Royal Medical Services in Jordan. JRMS. 2012;19:16-20.

Vitthala S, Tsoumpou I, Anjum ZK, Aziz NA. Use of Bakri balloon in post-partum hemorrhage: a series of 15 cases. Aus N Z J Obstet Gynaecol. 2009;49:191-4.

Arce-Herrera RM, Calderón-Cisneros E, Cruz-Cruz P, Díaz-Velázquez MF, Medécigo-Micete AC, Torres-Arreola LP. Guía de práctica clínica, hemorragia obstétrica en la segunda mitad del embarazo. Rev Med Inst Mex Seguro Soc. 2012;50:673-82.

Callaghan WM, Creanga AA, Kuklina EV. Severe maternal morbidity among delivery and postpartum hospitalizations in the United States. Obstet Gynecol. 2012;120:1029-36.

International Federation of Gynecology and Obstetrics (FIGO) safe motherhood and new born health (SMNH) committee. FIGO Guidelines. Prevention and treatment of postpartum hemorrhage in low resource settings. FIGO. 2012;117:108-18.

Dabelea V, Schultze PM, McDuffie RS. Intrauterine ballon tamponade in the management of postpartum hemorrhage. Am J Perinatol. 2007;24:359-64.

Flood KM, Said S, Geary M, Robson M, Fitzpatrick C, Malone F. Changing trends in peripartum hysterectomy over the last 4 decades. Am J Obstet Gynecol. 2009; 200:32.e1-e6.

Sakse A, Weber T, Nickelsen C, Secher NJ. Peripartum hysterectomy in Denmark 1995-2004. Acta Obstet Gynecol Scand. 2007;86:1472-5.

How to Cite

1.
Reynosa-Oviedo Y, López-Vera EA, Bazaldúa-Cruz JJ, Martínez-Salazar GJ. Efficacy and safety of uterine tamponade to control bleeding and reduce obstetric hysterectomy. Historic cohort in Nuevo León, México, 2013. Rev. colomb. obstet. ginecol. [Internet]. 2015 Sep. 30 [cited 2024 May 17];66(3):186-94. Available from: https://revista.fecolsog.org/index.php/rcog/article/view/23

Downloads

Download data is not yet available.

Published

2015-09-30

Issue

Section

Original Research
QR Code

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
Crossref Cited-by logo